Y Rajesh, TD Kanneganti - Cells, 2022 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a neurodegenerative disorder molecularly characterized by the formation of amyloid β (Aβ) plaques and type 2 microtubule-associated protein (Tau) …
Y Rajesh, TD Kanneganti - Cells, 2022 - europepmc.org
Alzheimer's disease (AD) is a neurodegenerative disorder molecularly characterized by the formation of amyloid β (Aβ) plaques and type 2 microtubule-associated protein (Tau) …
Y Rajesh, TD Kanneganti - Cells, 2022 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a neurodegenerative disorder molecularly characterized by the formation of amyloid β (Aβ) plaques and type 2 microtubule-associated protein (Tau) …
Y Rajesh, TD Kanneganti - Cells, 2022 - search.proquest.com
Alzheimer's disease (AD) is a neurodegenerative disorder molecularly characterized by the formation of amyloid β (Aβ) plaques and type 2 microtubule-associated protein (Tau) …
Y Rajesh, TD Kanneganti - Cells (2073-4409), 2022 - search.ebscohost.com
Alzheimer's disease (AD) is a neurodegenerative disorder molecularly characterized by the formation of amyloid β (Aβ) plaques and type 2 microtubule-associated protein (Tau) …
Alzheimer's disease (AD) is a neurodegenerative disorder molecularly characterized by the formation of amyloid β (Aβ) plaques and type 2 microtubule-associated protein (Tau) …